Rivoceranib-Airuika Combo Improves Survival in Liver Cancer Subset

🔗 Access full article via CureToday

Rivoceranib plus Airuika demonstrates improvement for survival in patients with unresectable hepatocellular carcinoma, a subset of liver cancer.